学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
Bisphosphonates in the treatment of skeletal metastases
被引:30
作者
:
Conte, P
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Modena & Reggio Emilia, Dept Haematol & Oncol, Modena, Italy
Conte, P
Coleman, R
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Modena & Reggio Emilia, Dept Haematol & Oncol, Modena, Italy
Coleman, R
机构
:
[1]
Univ Modena & Reggio Emilia, Dept Haematol & Oncol, Modena, Italy
[2]
Weston Pk Hosp, Canc Res Ctr, Yorkshire Acad Unit Clin Oncol, Sheffield, S Yorkshire, England
来源
:
SEMINARS IN ONCOLOGY
|
2004年
/ 31卷
/ 05期
关键词
:
D O I
:
10.1053/j.seminoncol.2004.07.024
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
引用
收藏
页码:59 / 63
页数:5
相关论文
共 46 条
[1]
Extended safety profile of oral clodronate after long-term use in primary breast cancer patients
Atula, S
论文数:
0
引用数:
0
h-index:
0
机构:
Schering Oy, Helsinki 00101, Finland
Atula, S
Powles, T
论文数:
0
引用数:
0
h-index:
0
机构:
Schering Oy, Helsinki 00101, Finland
Powles, T
Paterson, A
论文数:
0
引用数:
0
h-index:
0
机构:
Schering Oy, Helsinki 00101, Finland
Paterson, A
McCloskey, E
论文数:
0
引用数:
0
h-index:
0
机构:
Schering Oy, Helsinki 00101, Finland
McCloskey, E
Nevalainen, J
论文数:
0
引用数:
0
h-index:
0
机构:
Schering Oy, Helsinki 00101, Finland
Nevalainen, J
Kanis, J
论文数:
0
引用数:
0
h-index:
0
机构:
Schering Oy, Helsinki 00101, Finland
Kanis, J
[J].
DRUG SAFETY,
2003,
26
(09)
: 661
-
671
[2]
Dosing regimens and main adverse events of bisphosphonates
Body, JJ
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Support Care & Bone Dis Clin, B-1000 Brussels, Belgium
Body, JJ
[J].
SEMINARS IN ONCOLOGY,
2001,
28
(04)
: 49
-
53
[3]
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies
Body, JJ
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Body, JJ
Diel, IJ
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Diel, IJ
Lichinitzer, M
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Lichinitzer, M
Lazarev, A
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Lazarev, A
Pecherstorfer, M
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Pecherstorfer, M
Bell, R
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Bell, R
Tripathy, D
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Tripathy, D
Bergstronn, B
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Bergstronn, B
[J].
BRITISH JOURNAL OF CANCER,
2004,
90
(06)
: 1133
-
1137
[4]
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases
Body, JJ
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Body, JJ
Diel, IJ
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Diel, IJ
Lichinitser, MR
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Lichinitser, MR
Kreuser, ED
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Kreuser, ED
Dornoff, W
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Dornoff, W
Gorbunova, VA
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Gorbunova, VA
Budde, M
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Budde, M
Bergström, B
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Bergström, B
[J].
ANNALS OF ONCOLOGY,
2003,
14
(09)
: 1399
-
1405
[5]
A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastatic bone disease
Castel, LD
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA
Castel, LD
Bajwa, K
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA
Bajwa, K
Markle, JP
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA
Markle, JP
Timbie, JW
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA
Timbie, JW
Zacker, C
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA
Zacker, C
Schulman, KA
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA
Schulman, KA
[J].
SUPPORTIVE CARE IN CANCER,
2001,
9
(07)
: 545
-
551
[6]
Coleman R E, 2000, Oncologist, V5, P463, DOI 10.1634/theoncologist.5-6-463
[7]
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
Coleman, RE
论文数:
0
引用数:
0
h-index:
0
机构:
Weston Pk Hosp, Ctr Canc Res, Yorkshire Canc Res Dept Clin Oncol, Yorkshire Canc Res, Sheffield S10 2SJ, S Yorkshire, England
Weston Pk Hosp, Ctr Canc Res, Yorkshire Canc Res Dept Clin Oncol, Yorkshire Canc Res, Sheffield S10 2SJ, S Yorkshire, England
Coleman, RE
[J].
CANCER TREATMENT REVIEWS,
2001,
27
(03)
: 165
-
176
[8]
Protein geranylgeranylation is required for osteoclast formation, function, and survival: Inhibition by bisphosphonates and GGTI-298
Coxon, FP
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
Coxon, FP
Helfrich, MH
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
Helfrich, MH
Van't Hof, R
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
Van't Hof, R
Sebti, S
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
Sebti, S
Ralston, SH
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
Ralston, SH
Hamilton, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
Hamilton, A
Rogers, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
Rogers, MJ
[J].
JOURNAL OF BONE AND MINERAL RESEARCH,
2000,
15
(08)
: 1467
-
1476
[9]
Delea T, 2004, BONE, V34, pS86
[10]
Diel I J, 2000, Clin Breast Cancer, V1, P43, DOI 10.3816/CBC.2000.n.003
←
1
2
3
4
5
→
共 46 条
[1]
Extended safety profile of oral clodronate after long-term use in primary breast cancer patients
Atula, S
论文数:
0
引用数:
0
h-index:
0
机构:
Schering Oy, Helsinki 00101, Finland
Atula, S
Powles, T
论文数:
0
引用数:
0
h-index:
0
机构:
Schering Oy, Helsinki 00101, Finland
Powles, T
Paterson, A
论文数:
0
引用数:
0
h-index:
0
机构:
Schering Oy, Helsinki 00101, Finland
Paterson, A
McCloskey, E
论文数:
0
引用数:
0
h-index:
0
机构:
Schering Oy, Helsinki 00101, Finland
McCloskey, E
Nevalainen, J
论文数:
0
引用数:
0
h-index:
0
机构:
Schering Oy, Helsinki 00101, Finland
Nevalainen, J
Kanis, J
论文数:
0
引用数:
0
h-index:
0
机构:
Schering Oy, Helsinki 00101, Finland
Kanis, J
[J].
DRUG SAFETY,
2003,
26
(09)
: 661
-
671
[2]
Dosing regimens and main adverse events of bisphosphonates
Body, JJ
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Support Care & Bone Dis Clin, B-1000 Brussels, Belgium
Body, JJ
[J].
SEMINARS IN ONCOLOGY,
2001,
28
(04)
: 49
-
53
[3]
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies
Body, JJ
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Body, JJ
Diel, IJ
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Diel, IJ
Lichinitzer, M
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Lichinitzer, M
Lazarev, A
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Lazarev, A
Pecherstorfer, M
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Pecherstorfer, M
Bell, R
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Bell, R
Tripathy, D
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Tripathy, D
Bergstronn, B
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Brussels, Belgium
Bergstronn, B
[J].
BRITISH JOURNAL OF CANCER,
2004,
90
(06)
: 1133
-
1137
[4]
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases
Body, JJ
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Body, JJ
Diel, IJ
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Diel, IJ
Lichinitser, MR
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Lichinitser, MR
Kreuser, ED
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Kreuser, ED
Dornoff, W
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Dornoff, W
Gorbunova, VA
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Gorbunova, VA
Budde, M
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Budde, M
Bergström, B
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Brussels, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
Bergström, B
[J].
ANNALS OF ONCOLOGY,
2003,
14
(09)
: 1399
-
1405
[5]
A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastatic bone disease
Castel, LD
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA
Castel, LD
Bajwa, K
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA
Bajwa, K
Markle, JP
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA
Markle, JP
Timbie, JW
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA
Timbie, JW
Zacker, C
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA
Zacker, C
Schulman, KA
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA
Schulman, KA
[J].
SUPPORTIVE CARE IN CANCER,
2001,
9
(07)
: 545
-
551
[6]
Coleman R E, 2000, Oncologist, V5, P463, DOI 10.1634/theoncologist.5-6-463
[7]
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
Coleman, RE
论文数:
0
引用数:
0
h-index:
0
机构:
Weston Pk Hosp, Ctr Canc Res, Yorkshire Canc Res Dept Clin Oncol, Yorkshire Canc Res, Sheffield S10 2SJ, S Yorkshire, England
Weston Pk Hosp, Ctr Canc Res, Yorkshire Canc Res Dept Clin Oncol, Yorkshire Canc Res, Sheffield S10 2SJ, S Yorkshire, England
Coleman, RE
[J].
CANCER TREATMENT REVIEWS,
2001,
27
(03)
: 165
-
176
[8]
Protein geranylgeranylation is required for osteoclast formation, function, and survival: Inhibition by bisphosphonates and GGTI-298
Coxon, FP
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
Coxon, FP
Helfrich, MH
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
Helfrich, MH
Van't Hof, R
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
Van't Hof, R
Sebti, S
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
Sebti, S
Ralston, SH
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
Ralston, SH
Hamilton, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
Hamilton, A
Rogers, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
Rogers, MJ
[J].
JOURNAL OF BONE AND MINERAL RESEARCH,
2000,
15
(08)
: 1467
-
1476
[9]
Delea T, 2004, BONE, V34, pS86
[10]
Diel I J, 2000, Clin Breast Cancer, V1, P43, DOI 10.3816/CBC.2000.n.003
←
1
2
3
4
5
→